Slowing of growth in height and weight on stimulants: a characteristic pattern.
about
Understanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular functionPrevalence of overweight in children and adolescents with attention deficit hyperactivity disorder and autism spectrum disorders: a chart reviewLong-term exposure to oral methylphenidate or dl-amphetamine mixture in peri-adolescent rhesus monkeys: effects on physiology, behavior, and dopamine system developmentTreating attention-deficit/hyperactivity disorder beyond symptom control alone in children and adolescents: a review of the potential benefits of long-acting stimulantsThe interactive effects of methylphenidate and ethanol on ethanol consumption and locomotor activity in miceA clinical review of outcomes of the multimodal treatment study of children with attention-deficit/hyperactivity disorder (MTA).A naturalistic 10-year prospective study of height and weight in children with attention-deficit hyperactivity disorder grown up: sex and treatment effects.ADHD, stimulant treatment, and growth: a longitudinal study.Using stimulants for attention-deficit/hyperactivity disorder: clinical approaches and challenges.European guidelines on managing adverse effects of medication for ADHD.Methylphenidate and the response to growth hormone treatment in short children born small for gestational age.Body weight and ADHD: examining the role of self-regulation.ADHD and overweight in boys: cross-sectional study with birth weight as a controlled factor.Piloting a new approach to the treatment of obesity using dexamphetamine.Growth on stimulant medication; clarifying the confusion: a review.The effect of ADHD on the life of an individual, their family, and community from preschool to adult lifeThe safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder.The effects of long-term medication on growth in children and adolescents with ADHD: an observational study of a large cohort of real-life patientsNTP-CERHR Expert Panel Report on the reproductive and developmental toxicity of methylphenidate.NTP-CERHR Expert Panel Report on the reproductive and developmental toxicity of amphetamine and methamphetamine.Dexamphetamine use for management of obesity and hypersomnolence following hypothalamic injury.Long-term outcomes of stimulant medication in attention-deficit hyperactivity disorder.Stimulant medication effects on growth and bone age in children with attention-deficit/hyperactivity disorder: a prospective cohort study.Weight loss on stimulant medication: how does it affect body composition and bone metabolism? - A prospective longitudinal studyTreatment of attention deficit hyperactivity disorder in children and adolescents: safety considerations.The role of pharmacotherapy in the management of self-regulation difficulties in young childrenStimulant medication in pre-school children in New South Wales.Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder During Adolescence in the Primary Care Setting: A Concise ReviewRelationship of hyperactivity/inattention with adiposity and lifestyle characteristics in preschool children.Dietary intake, growth and development of children with ADHD in a randomized clinical trial of Ritalin and Melatonin co-administration: Through circadian cycle modification or appetite enhancement?Sexual maturation among youth with ADHD and the impact of stimulant medication.Examining the relationship between attention-deficit/hyperactivity disorder and overweight in children and adolescents.Long-term, open-label extension study of guanfacine extended release in children and adolescents with ADHD.Height, weight, IGF-I, IGFBP-3 and thyroid functions in prepubertal children with attention deficit hyperactivity disorder: effect of methylphenidate treatment.Growth perturbations from stimulant medications and inhaled corticosteroids.Effects of osmotic-release methylphenidate on height and weight in children with attention-deficit hyperactivity disorder (ADHD) following up to four years of treatment.Co-occurring weight problems among children with attention deficit/hyperactivity disorder: the role of executive functioning.Prevalence of Overweight and Obesity in Children and Adolescents With ADHD: The Significance of Comorbidities and Pharmacotherapy.Effect of methylphenidate treatment on appetite and levels of leptin, ghrelin, adiponectin, and brain-derived neurotrophic factor in children and adolescents with attention deficit and hyperactivity disorder.Prevalence of overweight, obesity and metabolic syndrome components in children, adolescents and young adults with type 1 diabetes mellitus.
P2860
Q22252308-C270A828-593C-4BD1-8639-9C0DBF7CF1F3Q25257179-A923EABE-4205-4B24-A3E7-3374F3F1BF13Q28389867-1F9A7102-32EA-4C88-9159-72BEAD1F66CDQ33746664-A0D9A490-F827-4421-AF3B-17100907D0A7Q33822439-7CD5E5F7-F4D9-41B2-85F8-1E0061A5CD23Q33925017-7FC8EFB8-B19E-4926-81DC-E57552160659Q34147604-844129B7-08ED-46C0-87A9-C609B76F2873Q34263102-488DD010-63B3-4046-A052-82FDDE038EB5Q34362939-E7F66DDD-C0BE-4281-9B13-CD61A5F42595Q34448884-FCE349BD-B0CA-477D-852E-28243E4F073BQ34541726-1B6A1F11-6983-4A79-B154-B57B3D43486AQ34576461-56A71615-451D-49EC-8C19-C44D10175BE8Q34924401-AE670EDF-8026-46A7-AC1D-FAD4CC5A9F60Q35063613-3C196427-0CF8-4A4A-9278-1E16BEC1338EQ35284563-D9C41B69-61D2-4601-A8D8-374B0477EF9DQ35575701-117FC8EC-0758-4588-929D-38843F155F47Q36082025-C263708E-718E-4DDF-AB28-785E8D30ABC7Q36220220-07EEAE6F-30F1-4852-BE30-7EDA794C83C8Q36243099-3FA54EEE-8EBA-45EA-8398-E8D89C20AEA2Q36259217-F5B0DC0E-3E81-4C4B-9008-70D012A3599DQ36430576-869966F9-E223-4AC6-A234-B63F7ECACCBCQ36453293-DE872BDC-3C04-4807-889B-D71B9F87A688Q36530052-03D6DAB0-28AC-432C-AB23-4A4DA8E84BCFQ36547771-AC80870A-8CC2-4B13-9B49-CF796DC6D165Q36694580-14C768AC-637C-4DDF-AF49-DEC79C5E19ACQ37204884-05F1CA82-0E52-4338-A41D-ED0F21150FABQ37887060-02C5745A-8A2B-425F-8576-6441ABF81328Q38840904-8A36D25F-B800-47AA-B950-57FE209DC0EBQ39668819-62364526-12E5-4EEF-A8D7-11C631F328C2Q41500363-5B819300-2680-407F-B11A-9020CD31D586Q44179017-D2F8A1C1-8E4F-4008-8020-E04DE8FEA7AEQ45204981-D1E92A04-24BB-4EF9-922E-88EE8EA170F4Q46140463-7B7F0150-CC3B-451F-9F3F-9AB51CF2E608Q46408333-FFEA262A-FD47-4A66-80BB-95C26F2656F1Q47156286-22267827-6959-4673-BB7E-3D771EC52B1BQ47336578-F49C8B11-2F96-43B1-B757-7E32568A9B45Q47338771-5A454A30-FEE0-4EAB-A854-36B098034550Q47419598-19ABCE3A-D0DC-4DF1-985C-A5C986B26C3DQ48678229-973246E1-BCA9-46D5-897E-559DAD7CE1DAQ51140236-EE6ACDC5-48DC-4958-A8F4-0B3B53C1BDB4
P2860
Slowing of growth in height and weight on stimulants: a characteristic pattern.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Slowing of growth in height and weight on stimulants: a characteristic pattern.
@ast
Slowing of growth in height and weight on stimulants: a characteristic pattern.
@en
type
label
Slowing of growth in height and weight on stimulants: a characteristic pattern.
@ast
Slowing of growth in height and weight on stimulants: a characteristic pattern.
@en
prefLabel
Slowing of growth in height and weight on stimulants: a characteristic pattern.
@ast
Slowing of growth in height and weight on stimulants: a characteristic pattern.
@en
P2860
P1476
Slowing of growth in height and weight on stimulants: a characteristic pattern.
@en
P2093
P2860
P304
P356
10.1046/J.1440-1754.2003.00107.X
P577
2003-04-01T00:00:00Z